Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled trial of injectable AAPB in acute ischemic stroke
CTR20261131Phase 2Active
- Sponsor
- Jiangsu Kanion Pharmaceutical Co., Ltd.
- Start
- Mar 2026
- Modality
- Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 2-aminoethoxydiphenylborate in brain infarction, sponsored by Jiangsu Kanion Pharmaceutical Co., Ltd.. Started Mar 2026; status: active.
02
Drugs
2-aminoethoxydiphenylborate
03
Conditions
brain infarction
Beyond the preview
Go deeper on CTR20261131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20261131.